Michael Sinclair

Currently holds a position at Opiant Pharmaceuticals Inc

2.4

2.4

Position	Company	Period
Executive Chairman of the Board	Opiant Pharmaceuticals Inc	Nov. 26, 2012 -
Executive Chairman of the Board, Interim Chief Financial Officer	Opiant Pharmaceuticals Inc	Nov. 5, 2012 - Nov. 26, 2012
Executive Chairman of the Board	Opiant Pharmaceuticals Inc	Nov. 29, 2010 - Nov. 5, 2012

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2022-06-15	2022-06-15	Opiant Pharmaceuticals Inc (OPNT)	S Sale	38,270 -46.9% 473.73 US$4,403,338	38,270 -46.9%	473.73	US$4,403,338
2022-06-15	2022-06-14	Opiant Pharmaceuticals Inc (OPNT)	S Sale	50,851 -37.3% 144.12 US$559,977	50,851 -37.3%	144.12	US$559,977
2022-06-15	2022-06-13	Opiant Pharmaceuticals Inc (OPNT)	S Sale	89,797 +17.6% 455.08 US$3,889,958	89,797 +17.6%	455.08	US$3,889,958
2022-06-13	2022-06-09	Opiant Pharmaceuticals Inc (OPNT)	S Sale	7,896 -19.4% 12.25 US$96,726	7,896 -19.4%	12.25	US$96,726
2022-06-08	2022-06-07	Opiant Pharmaceuticals Inc (OPNT)	S Sale	800 -1.9% 12.86 US$10,288	800 -1.9%	12.86	US$10,288
2022-06-08	2022-06-06	Opiant Pharmaceuticals Inc (OPNT)	S Sale	7,688 -15.6% 12.94 US$99,483	7,688 -15.6%	12.94	US$99,483
2022-06-06	2022-06-03	Opiant Pharmaceuticals Inc (OPNT)	S Sale	10,264 -17.3% 13.59 US$139,488	10,264 -17.3%	13.59	US$139,488
2022-06-06	2022-06-02	Opiant Pharmaceuticals Inc (OPNT)	S Sale	9,736 -14.1% 13.88 US$135,136	9,736 -14.1%	13.88	US$135,136
2020-09-24	2020-09-22	Rockwood Realisation Plc	B Purchase	510 9.79 £4,993	510	9.79	£4,993
2019-09-13	2019-09-12	Opiant Pharmaceuticals Inc (OPNT)	S Sale	60,000 -46.4% 12.52 US$751,200	60,000 -46.4%	12.52	US$751,200